West NileVirus Vaccine
For the vaccination of healthy horses 6 months of
age or older as an aid in the prevention of viremia caused by West Nile
Virus. Duration of immunity studies are in progress.
Administration and Dosage:
Shake well before use. Using aseptic technique,
inoculate horses intramuscularly with a 1 mL dose. Administer a second 1
mL does intramuscularly in 3-4 weeks using a different injection site.
Revaccinate annually and prior to anticipated exposure with a single 1
mL intramuscular dose.
Store at 35-45°F (2-7°C). Protect from freezing. Do
not vaccinate within 21 days before slaughter. Anaphylactoid reactions
may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory
conditions and shown to meet all Federal standards for safety and
efficacy in normal, healthy, immunocompetent animals. This level of
performance may be affected by conditions such as stress, weather,
nutrition, disease, parasitism, other treatments, individual
idiosyncrasies, or impaired immunological competency. These factors
should be considered by the user when evaluating product performance or
freedom from reactions.